Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia

The development of acute lymphoblastic leukemia in an existing myeloproliferative neoplasm is rare with historical cases unable to differentiate between concomitant malignancies or leukemic transformation. Molecular studies of coexisting JAK2 V617F-positive myeloproliferative neoplasms and mature B...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephen E. Langabeer, Karl Haslam, David O’Brien, Johanna Kelly, Claire Andrews, Ciara Ryan, Richard Flavin, Patrick J. Hayden, Christopher L. Bacon
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2016/6545861
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551883365941248
author Stephen E. Langabeer
Karl Haslam
David O’Brien
Johanna Kelly
Claire Andrews
Ciara Ryan
Richard Flavin
Patrick J. Hayden
Christopher L. Bacon
author_facet Stephen E. Langabeer
Karl Haslam
David O’Brien
Johanna Kelly
Claire Andrews
Ciara Ryan
Richard Flavin
Patrick J. Hayden
Christopher L. Bacon
author_sort Stephen E. Langabeer
collection DOAJ
description The development of acute lymphoblastic leukemia in an existing myeloproliferative neoplasm is rare with historical cases unable to differentiate between concomitant malignancies or leukemic transformation. Molecular studies of coexisting JAK2 V617F-positive myeloproliferative neoplasms and mature B cell malignancies indicate distinct disease entities arising in myeloid and lymphoid committed hematopoietic progenitor cells, respectively. Mutations of CALR in essential thrombocythemia appear to be associated with a distinct phenotype and a lower risk of thrombosis yet their impact on disease progression is less well defined. The as yet undescribed scenario of pro-B cell acute lymphoblastic leukemia arising in CALR mutated essential thrombocythemia is presented. Intensive treatment for the leukemia allowed for expansion of the original CALR mutated clone. Whether CALR mutations in myeloproliferative neoplasms predispose to the acquisition of additional malignancies, particularly lymphoproliferative disorders, is not yet known.
format Article
id doaj-art-6e7474b03b2c455185d6e7c45669da52
institution Kabale University
issn 2090-6560
2090-6579
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-6e7474b03b2c455185d6e7c45669da522025-02-03T06:00:18ZengWileyCase Reports in Hematology2090-65602090-65792016-01-01201610.1155/2016/65458616545861Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential ThrombocythemiaStephen E. Langabeer0Karl Haslam1David O’Brien2Johanna Kelly3Claire Andrews4Ciara Ryan5Richard Flavin6Patrick J. Hayden7Christopher L. Bacon8Cancer Molecular Diagnostics, St. James’s Hospital, Dublin 8, IrelandCancer Molecular Diagnostics, St. James’s Hospital, Dublin 8, IrelandDepartment of Haematology, St. James’s Hospital, Dublin 8, IrelandDepartment of Clinical Genetics, Our Lady’s Children’s Hospital, Dublin 12, IrelandDepartment of Haematology, St. James’s Hospital, Dublin 8, IrelandDepartment of Histopathology, St. James’s Hospital, Dublin 8, IrelandDepartment of Histopathology, St. James’s Hospital, Dublin 8, IrelandDepartment of Haematology, St. James’s Hospital, Dublin 8, IrelandDepartment of Haematology, St. James’s Hospital, Dublin 8, IrelandThe development of acute lymphoblastic leukemia in an existing myeloproliferative neoplasm is rare with historical cases unable to differentiate between concomitant malignancies or leukemic transformation. Molecular studies of coexisting JAK2 V617F-positive myeloproliferative neoplasms and mature B cell malignancies indicate distinct disease entities arising in myeloid and lymphoid committed hematopoietic progenitor cells, respectively. Mutations of CALR in essential thrombocythemia appear to be associated with a distinct phenotype and a lower risk of thrombosis yet their impact on disease progression is less well defined. The as yet undescribed scenario of pro-B cell acute lymphoblastic leukemia arising in CALR mutated essential thrombocythemia is presented. Intensive treatment for the leukemia allowed for expansion of the original CALR mutated clone. Whether CALR mutations in myeloproliferative neoplasms predispose to the acquisition of additional malignancies, particularly lymphoproliferative disorders, is not yet known.http://dx.doi.org/10.1155/2016/6545861
spellingShingle Stephen E. Langabeer
Karl Haslam
David O’Brien
Johanna Kelly
Claire Andrews
Ciara Ryan
Richard Flavin
Patrick J. Hayden
Christopher L. Bacon
Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia
Case Reports in Hematology
title Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia
title_full Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia
title_fullStr Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia
title_full_unstemmed Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia
title_short Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia
title_sort acute lymphoblastic leukemia arising in calr mutated essential thrombocythemia
url http://dx.doi.org/10.1155/2016/6545861
work_keys_str_mv AT stephenelangabeer acutelymphoblasticleukemiaarisingincalrmutatedessentialthrombocythemia
AT karlhaslam acutelymphoblasticleukemiaarisingincalrmutatedessentialthrombocythemia
AT davidobrien acutelymphoblasticleukemiaarisingincalrmutatedessentialthrombocythemia
AT johannakelly acutelymphoblasticleukemiaarisingincalrmutatedessentialthrombocythemia
AT claireandrews acutelymphoblasticleukemiaarisingincalrmutatedessentialthrombocythemia
AT ciararyan acutelymphoblasticleukemiaarisingincalrmutatedessentialthrombocythemia
AT richardflavin acutelymphoblasticleukemiaarisingincalrmutatedessentialthrombocythemia
AT patrickjhayden acutelymphoblasticleukemiaarisingincalrmutatedessentialthrombocythemia
AT christopherlbacon acutelymphoblasticleukemiaarisingincalrmutatedessentialthrombocythemia